Haller, P. M., Jarolim, P., Palazzolo, M., Bellavia, A., Harrington, J., Healey, J. S., … Morrow, D. A. (2024). Heart failure risk assessment using biomarkers in patients with atrial fibrillation: analysis of 32,041 patients from the COMBINE-AF study. In European Heart Journal (Vol. 45). Oxford University Press (OUP). https://doi.org/10.1093/eurheartj/ehae666.486

Haller, P. M., P. Jarolim, M. Palazzolo, A. Bellavia, J. Harrington, J. S. Healey, S. J. Connolly, et al. “Heart failure risk assessment using biomarkers in patients with atrial fibrillation: analysis of 32,041 patients from the COMBINE-AF study.” In European Heart Journal, Vol. 45. Oxford University Press (OUP), 2024. https://doi.org/10.1093/eurheartj/ehae666.486.

Haller PM, Jarolim P, Palazzolo M, Bellavia A, Harrington J, Healey JS, et al. Heart failure risk assessment using biomarkers in patients with atrial fibrillation: analysis of 32,041 patients from the COMBINE-AF study. In: European Heart Journal. Oxford University Press (OUP); 2024.

Haller, P. M., et al. “Heart failure risk assessment using biomarkers in patients with atrial fibrillation: analysis of 32,041 patients from the COMBINE-AF study.” European Heart Journal, vol. 45, no. Supplement_1, Oxford University Press (OUP), 2024. Crossref, doi:10.1093/eurheartj/ehae666.486.

Haller PM, Jarolim P, Palazzolo M, Bellavia A, Harrington J, Healey JS, Connolly SJ, Eikelboom J, Granger CB, Patel MR, Ruff CT, Wallentin L, Giugliano RP, Morrow DA. Heart failure risk assessment using biomarkers in patients with atrial fibrillation: analysis of 32,041 patients from the COMBINE-AF study. European Heart Journal. Oxford University Press (OUP); 2024.